US equities
|
MU
$1,086.40
▲+3.91%
NVDA
$236.78
▼-1.03%
SNDK
$1,719.27
▲+3.54%
SPCX
$167.10
▼-2.80%
AMD
$644.50
▼-0.76%
TSLA
$377.43
▼-0.86%
INTC
$112.61
▲+0.10%
AAPL
$336.59
▲+0.89%
MU
$1,086.40
▲+3.91%
NVDA
$236.78
▼-1.03%
SNDK
$1,719.27
▲+3.54%
SPCX
$167.10
▼-2.80%
AMD
$644.50
▼-0.76%
TSLA
$377.43
▼-0.86%
INTC
$112.61
▲+0.10%
AAPL
$336.59
▲+0.89%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about TYPTF
Recent news which mentions TYPTF
Tryptamine Therapeutics Advances Psilocin-Based IV Infusion To Phase 2 Clinical Trials
November 19, 2024
Tickers
NEWS
TYPTF
Tags
Tryptamine Therapeutics
Jason Carroll
TYPTF
From
Benzinga